CIK 0001751912 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | 6-K/A | FORM 6-K/A | 2026-08-13 |
| 2026-10-16 | 40-F/A | 40-F/A | 2025-12-31 |
| 2026-09-25 | 6-K | FORM 6-K | 2026-09-25 |
| 2026-09-24 | 6-K | FORM 6-K | 2026-09-24 |
| 2026-08-13 | 6-K | FORM 6-K | 2026-08-13 |
| 2026-07-02 | 6-K | FORM 6-K | 2026-07-02 |
| 2026-07-02 | SUPPL | SUPPL | |
| 2026-06-01 | 6-K | FORM 6-K | 2026-06-01 |
| 2026-05-26 | EFFECT | EFFECT items ,, | |
| 2026-05-26 | 6-K | FORM 6-K | 2026-05-26 |
| 2026-05-26 | SUPPL | SUPPL | |
| 2026-05-26 | F-X | FORM F-X | |
| 2026-05-26 | F-10 | F-10 | |
| 2026-05-22 | 6-K | FORM 6-K | 2026-05-22 |
| 2026-05-22 | SUPPL | SUPPL | |
| 2026-05-21 | SUPPL | SUPPL | |
| 2026-05-18 | 6-K | FORM 6-K | 2026-05-18 |
| 2026-05-15 | 6-K | FORM 6-K | 2026-05-15 |
| 2026-05-07 | S-8 | FORM S-8 | |
| 2026-04-27 | 6-K | FORM 6-K | 2026-04-27 |
| 2026-03-31 | 40-F | 40-F | 2025-12-31 |
| 2026-03-13 | 6-K | FORM 6-K | 2026-03-13 |
| 2026-02-13 | 6-K | FORM 6-K | 2026-02-13 |
| 2026-02-10 | 6-K | FORM 6-K | 2026-02-10 |
| 2026-01-23 | S-8 | FORM S-8 |
Forms on file (last 1,000): 6-K 14, D 7, SUPPL 4, EFFECT 2, F-X 2, F-10 2, S-8 2, D/A 2. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=NGEN (0.002 USD), /gw/filings/filings?ticker=NGEN&form=8-K, /gw/filings/facts?ticker=NGEN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange